Eliassen, Medidata to partner in EDC solution

Eliassen Group’s eClinical Solutions Division has signed a partnership agreement with Medidata Solutions, a provider of electronic clinical data capture (EDC), management and reporting solutions.
Register for free to listen to this article
Listen with Speechify
0:00
1:00
WAKEFIELD, Mass.—Eliassen Group's eClinical Solutions Division has signed a partnership agreement with Medidata Solutions, a provider of electronic clinical data capture (EDC), management and reporting solutions. As a member of Medidata's ASPire to Win program, Eliassen's eClinical Solutions Division will leverage its specialized clinical data management expertise to provide pharmaceutical, biotechnology and medical device companies with the ability to help maximize the benefits of Rave."Eliassen eClinical Solutions will be a valuable consulting service resource to Medidata customers who want to optimize Rave in their study environments and maximize their technology investment. Our team's significant hands-on experience in the set-up, deployment and execution of EDC for clinical trials enables us to support client requirements and deliver a robust clinical trial development process," says Susan Bornstein, EVP Eliassen Group eClinical Solutions.

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up of a researcher using a stylus to draw or interact with digital molecular structures on a blue scientific interface.
When molecules outgrow the limits of sketches and strings, researchers need a new way to describe and communicate them.
Portrait of Scott Weitze, Vice President of Research and Technical Standards at My Green Lab, beside text that reads “Tell us what you know: Bringing sustainability into scientific research,” with the My Green Lab logo.
Laboratories account for a surprising share of global emissions and plastic waste, making sustainability a priority for modern research.
3D illustration of RNA molecules on a gradient blue background.
With diverse emerging modalities and innovative delivery strategies, RNA therapeutics are tackling complex diseases and unmet medical needs.
Drug Discovery News September 2025 Issue
Latest IssueVolume 21 • Issue 3 • September 2025

September 2025

September 2025 Issue

Explore this issue